Article Details
Retrieved on: 2024-11-15 18:30:57
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details Boston Scientific's $3.7 billion acquisition of Axonics, a move to expand in the MedTech field, particularly in urology and sacral neuromodulation. This aligns with Boston Scientific's growth strategy amid competition with Medtronic.
Article found on: www.massdevice.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here